CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank92
Studio
Year-over-Year Change

Debt-to-equity ratio

Latest
0.04
↑ 101% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-7.09
Historical baseline
PeriodValueYoY Change
20250.04+100.2%
2024-20.58-6888.1%
2023-0.29-39.9%
2022-0.21+99.6%
2021-47.22-1376.0%
2020-3.20-690.7%
20190.54-
20180.00-
20170.00-
20160.00-